Southern Company today reported third-quarter earnings of $1.7 billion, or $1.55 per share, in 2025 compared with earnings of $1.5 billion, or $1.40 per share, in the third quarter of 2024. For the ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions First and only therapy to specifically target the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback